Clinical

Research suggests bioactive compounds in chocolate may help reduce the risk of type 2 diabetes. But not all chocolate offers the same benefits.

It’s a complex problem, like any disease, but eliminating it is within the world’s grasp.

The European Medicines Agency committee said the benefits of the new drug, Kisunla, did not outweigh the risks, and it recommended refusing marketing authorization for it.

Get the info you need on this new product, part of our drug news roundup for April.

A session on dementia at the BPAO annual health symposium highlighted key interventions for Black Canadians living with dementia.

Experts from the International Geriatric Diabetes Society recently developed the ‘4S Pathway.’

McMaster experts release comprehensive evidence-based guidelines for diagnosis, management, prevention and treatment of ‘long COVID.’

Is ADHD a construct rather than a discrete biological disease?